European Medicines Agency

The European Medicines Agency (EMA), based in the Netherlands and operating within the Medical, precision and optical instruments, watches and clocks (33) industry, has disclosed Scope 3 emissions primarily related to business travel.

For 2023, the EMA reported approximately 1,901,900 kg CO2e in total emissions, with Scope 3 business travel accounting for about 1,682,900 kg CO2e. This represents a significant increase from the previous year.

In 2022, total emissions were approximately 979,900 kg CO2e, with Scope 3 business travel at about 791,600 kg CO2e.

In 2021, total emissions were approximately 178,500 kg CO2e, and Scope 3 business travel was about 800 kg CO2e.

For 2020, total emissions were approximately 809,100 kg CO2e, with Scope 3 business travel contributing about 525,700 kg CO2e.

The EMA has not publicly disclosed specific carbon reduction targets or achievements. Data is reported directly by the European Medicines Agency and is not cascaded from a parent organisation. The organisation is noted to have missing data points for Scope 3 purchased goods and services.